$1.29 Earnings Per Share Expected for Mylan NV (NASDAQ:MYL) This Quarter

Share on StockTwits

Brokerages predict that Mylan NV (NASDAQ:MYL) will report $1.29 earnings per share (EPS) for the current quarter, according to Zacks. Four analysts have provided estimates for Mylan’s earnings, with estimates ranging from $1.27 to $1.32. Mylan reported earnings of $1.30 per share during the same quarter last year, which would suggest a negative year-over-year growth rate of 0.8%. The business is expected to report its next quarterly earnings report on Tuesday, February 25th.

According to Zacks, analysts expect that Mylan will report full year earnings of $4.31 per share for the current fiscal year, with EPS estimates ranging from $4.20 to $4.40. For the next fiscal year, analysts anticipate that the business will post earnings of $4.47 per share, with EPS estimates ranging from $4.30 to $4.67. Zacks’ EPS averages are a mean average based on a survey of sell-side analysts that cover Mylan.

Mylan (NASDAQ:MYL) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $1.17 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.14 by $0.03. Mylan had a return on equity of 18.80% and a net margin of 0.42%. The company had revenue of $2.96 billion during the quarter, compared to analyst estimates of $3.01 billion. During the same quarter in the previous year, the company posted $1.25 earnings per share. Mylan’s revenue was up 3.5% compared to the same quarter last year.

Several brokerages recently commented on MYL. ValuEngine raised Mylan from a “strong sell” rating to a “sell” rating in a report on Wednesday, October 2nd. Mizuho lifted their price objective on Mylan from $25.00 to $27.00 and gave the stock a “neutral” rating in a report on Tuesday, July 30th. Cfra lowered Mylan from a “hold” rating to a “sell” rating in a report on Tuesday, November 5th. BidaskClub lowered Mylan from a “hold” rating to a “sell” rating in a report on Thursday, November 7th. Finally, Evercore ISI reaffirmed a “buy” rating on shares of Mylan in a report on Friday, August 9th. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and eleven have assigned a buy rating to the company’s stock. Mylan currently has an average rating of “Hold” and an average price target of $27.97.

Shares of MYL traded up $0.04 during trading hours on Thursday, hitting $17.27. The stock had a trading volume of 5,291,138 shares, compared to its average volume of 6,651,576. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.43 and a quick ratio of 0.84. Mylan has a 12 month low of $16.63 and a 12 month high of $35.07. The firm has a market capitalization of $9.14 billion, a PE ratio of 3.77, a PEG ratio of 0.95 and a beta of 1.75. The stock has a fifty day moving average price of $18.53 and a 200 day moving average price of $19.32.

In other news, insider Goulds Bruce 8,000,000 shares of the firm’s stock in a transaction on Friday, November 8th. Insiders own 0.82% of the company’s stock.

Several institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in shares of Mylan by 19.2% in the second quarter. Vanguard Group Inc. now owns 56,048,375 shares of the company’s stock valued at $1,067,160,000 after acquiring an additional 9,026,215 shares in the last quarter. Pzena Investment Management LLC lifted its position in shares of Mylan by 0.4% in the second quarter. Pzena Investment Management LLC now owns 21,103,981 shares of the company’s stock valued at $401,820,000 after acquiring an additional 76,305 shares in the last quarter. Invesco Ltd. lifted its position in shares of Mylan by 4.1% in the second quarter. Invesco Ltd. now owns 17,031,971 shares of the company’s stock valued at $324,289,000 after acquiring an additional 664,498 shares in the last quarter. AQR Capital Management LLC lifted its position in shares of Mylan by 11.0% in the second quarter. AQR Capital Management LLC now owns 11,247,227 shares of the company’s stock valued at $213,473,000 after acquiring an additional 1,111,009 shares in the last quarter. Finally, Menora Mivtachim Holdings LTD. lifted its position in shares of Mylan by 4.3% in the third quarter. Menora Mivtachim Holdings LTD. now owns 6,698,254 shares of the company’s stock worth $132,491,000 after buying an additional 277,000 shares in the last quarter. Institutional investors and hedge funds own 84.01% of the company’s stock.

About Mylan

Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded-generic, brand-name, and over-the-counter (OTC) pharmaceutical products in North America, Europe, and internationally. It offers active pharmaceutical ingredients and finished dosage forms; and antiretroviral medicines to treat HIV/AIDS.

Featured Article: Market Indexes

Get a free copy of the Zacks research report on Mylan (MYL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Mylan (NASDAQ:MYL)

Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Bros. Advisors Lp Baker Purchases 1,902,173 Shares of Kodiak Sciences Inc.  Stock
Bros. Advisors Lp Baker Purchases 1,902,173 Shares of Kodiak Sciences Inc. Stock
ReShape Lifesciences Inc.  Major Shareholder Armistice Capital Master Fund Purchases 1,929 Shares
ReShape Lifesciences Inc. Major Shareholder Armistice Capital Master Fund Purchases 1,929 Shares
Iress  Stock Passes Below Two Hundred Day Moving Average of $13.00
Iress Stock Passes Below Two Hundred Day Moving Average of $13.00
AMP  Stock Price Passes Below Two Hundred Day Moving Average of $1.96
AMP Stock Price Passes Below Two Hundred Day Moving Average of $1.96
Lithium Americas  Stock Price Crosses Below Two Hundred Day Moving Average of $4.56
Lithium Americas Stock Price Crosses Below Two Hundred Day Moving Average of $4.56
First Derivatives  Shares Cross Below Two Hundred Day Moving Average of $2,679.21
First Derivatives Shares Cross Below Two Hundred Day Moving Average of $2,679.21


 
© 2006-2019 Zolmax.